A method of treating or preventing a bacterial infection in the lung of a subject by administering an inhaled antibiotic, such as tobramycin, and at least 37.5mg/day of an inhaled chelating agent, such as calcium EDTA, each in one or more doses, wherein the doses of the chelating agent and/or antibiotic is administered over a period of no more than 8h.